Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed (2019 - 2025)

Arcturus Therapeutics Holdings' Return on Capital Employed history spans 7 years, with the latest figure at 0.32% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.32%; the TTM value through Dec 2025 reached 0.32%, up 1.0%, while the annual FY2025 figure was 0.28%, 2.0% up from the prior year.
  • Return on Capital Employed reached 0.32% in Q4 2025 per ARCT's latest filing, down from 0.3% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.21% in Q1 2023 to a low of 0.75% in Q1 2022.
  • Average Return on Capital Employed over 5 years is 0.3%, with a median of 0.29% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: surged 96bps in 2023, then plummeted -61bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.65% in 2021, then surged by 108bps to 0.05% in 2022, then plummeted by -535bps to 0.22% in 2023, then tumbled by -52bps to 0.33% in 2024, then rose by 3bps to 0.32% in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Return on Capital Employed are 0.32% (Q4 2025), 0.3% (Q3 2025), and 0.26% (Q2 2025).